Safe Food_ Bacteria, Biotechnology, and Bioterrorism - Marion Nestle [202]
19. Engelberg S. Democrats’ new overseer is everybody’s Mr. Inside. NYT, August 19, 1994:A1,A16.
20. Coghlan A. Milk hormone data bottled up for years. New Scientist October 22, 1994:4. Millstone E, Brunner E, White I. Plagiarism or protecting public health? Nature 1994;371:647–648.
21. Wilson S. Fox in the cow barn. Nation, June 8, 1998:20. Montague P. How Monsanto “listens” to other opinions. Ecologist 1998;28(5):299–300. Reporters win lawsuit to thwart Fox-TV cover-up. BGH Bulletin, undated, accessed December 15, 2001. Online: www.foxbghsuit.com.
22. Schneider K. Lines drawn in a war over a milk hormone. NYT, March 9, 1994:A12.
23. Weldon VV. Testimony to the Joint Meeting of the FDA Food and Veterinary Medicine Advisory Committee Meetings, Washington DC, May 6–7, 1993 (written statement distributed at the meeting). Dr. Weldon was then vice president for public policy, Monsanto.
24. After committees meet, BGH decision left to FDA. Nutrition Week, May 14, 1993:2–3.
25. FDA. Interim guidance on the voluntary labeling of milk and milk products from cows that have not been treated with recombinant bovine somatotropin. FR 59:6279–6280, February 10, 1994.
26. Schneider K. Maine and Vermont restrict dairies’ use of a growth hormone. NYT, April 15, 1994:A16.
27. Kilman S. Dairy-food concerns launch products from cows not treated with hormone. WSJ, May 2, 1994:B7.
28. Burros M. More milk, more confusion: what should the label say? NYT, May 18, 1994:C1,C4.
29. King & Spalding. Mandatory labeling of milk and other foods derived from dairy cows supplemented with bovine somatotropin would be unlawful and unwise (memorandum). Washington, DC, April 28, 1993. A cover letter discloses the author as Mr. Richard A. Merrill, the former FDA counsel. These materials were included as part of the briefing materials for the FDA Food Advisory Committee hearings of May 6, 1993.
30. Schneider K. Question is raised on hormone maker’s ties to F.D.A. aides. NYT, April 18, 1994:A9.
31. GAO. Letter from Acting General Counsel Robert P. Murphy to the Honorables George E. Brown, Jr., David Obey, and Bernard Sanders (B257122), October 19, 1994. Quotations: 15,23.
32. Sanders B. GAO uncovers appearances of impropriety in FDA’s approval of rBGH (press release). U.S. House of Representatives, October 30, 1994. The release included detailed summaries of the involvement of the three FDA employees.
33. Bellow D. Vermont, the pure-food state. Nation, March 8, 1999:18–21. Brownlee S. Dollars for DNA: biotech seems near to living up to its hype. US News & World Report, May 25, 1998:48,50.
34. Aldrich L, Blisard N. Consumer acceptance of biotechnology: lessons from the rbST experience. Current Issues in Economics of Food Markets (USDA Agriculture Information Bulletin No. 747-01), December 1998.
35. Hoban TJ. Consumer Awareness and Acceptance of Bovine Somatotropin (BST). Washington, DC: Grocery Manufacturers of America, 1994. Grobe D, Douthitt R, Zepeda L. A model of consumers’ risk perceptions toward recombinant bovine growth hormone (rBGH): the impact of risk characteristics. Risk Analysis 1999;19:661–673.
36. Gilbert S. Fears over milk, long dismissed, still simmer. NYT, January 19, 1999:F7.
37. Kessler DA, Taylor MR, Maryanski JH, et al. The safety of foods developed by biotechnology. Science 1992;256:1747–1749, 1832.
38. FDA. Statement of policy: foods derived from new plant varieties: notice. FR 57:22984–23005, May 29, 1992. Quotation: 22985.
39. FDA. Premarket notice concerning bioengineered foods: proposed rule. FR 66:4706–4738, January 18, 2001.
40. Ingersoll B. New policy eases market path for bioengineered foods. WSJ, May 26, 1992: B1,B6.
41. Kim J. Genetic agriculture gets go-ahead. USA Today, May 27, 1992:3B.
42. Burros M. Documents show officials disagreed on altered food. NYT, December 1, 1999:A18. Druker SM. Why Food and